| Bioactivity | COTI-219 is an orally active inhibitor of KRAS. COTI-219 has antitumor activity[1]. |
| Name | COTI-219 |
| CAS | 1039455-85-0 |
| Formula | C17H18N6S |
| Molar Mass | 338.43 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sandra E., et al. Treatment of kras mutant cancers. WO2022109307A1.2022-05-27. |